《大行報告》高盛上調農夫山泉(09633.HK)目標價至50元 評級「買入」
高盛發表報告上調農夫山泉(09633.HK)目標價至50元(原本48.7元),評級「買入」。
高盛將農夫山泉2021至2023年的盈利預測上調4%至5%,主要反映今年下半年飲料需求的增長。預期公司下半年增長將超過行業增長,因為水的銷售穩固,及茶或果汁銷售恢復。此外,由於公司已獲得大部分低成本庫存,PET(滌綸樹脂)成本對公司利潤率影響較小。
展望明年,該行預計,隨著新產品做出更大的銷售貢獻,銷售額將繼續保持中至高十位數增長,不過明年上半年,PET成本上升將對利潤率產生更大的影響和壓力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.